Repligen
RGEN
#2045
Rank
โ‚น834.29 B
Marketcap
โ‚น14,821
Share price
-0.47%
Change (1 day)
23.03%
Change (1 year)
Categories

Revenue for Repligen (RGEN)

Revenue in 2025 (TTM): โ‚น61.23 Billion

According to Repligen 's latest financial reports the company's current revenue (TTM ) is โ‚น63.59 Billion. In 2024 the company made a revenue of โ‚น54.42 Billion an increase over the revenue in the year 2023 that were of โ‚น51.73 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Repligen from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น61.23 B12.51%
2024 โ‚น54.42 B5.2%
2023 โ‚น51.73 B-22%
2022 โ‚น66.32 B32.9%
2021 โ‚น49.90 B86.32%
2020 โ‚น26.78 B38.99%
2019 โ‚น19.27 B42.04%
2018 โ‚น13.56 B50.44%
2017 โ‚น9.01 B26.94%
2016 โ‚น7.10 B27.97%
2015 โ‚น5.55 B37.84%
2014 โ‚น4.02 B-4.37%
2013 โ‚น4.21 B23.53%
2012 โ‚น3.40 B
2010 โ‚น1.17 B22.54%
2009 โ‚น0.96 B-28.83%
2008 โ‚น1.34 B74.55%
2007 โ‚น0.77 B31.6%
2006 โ‚น0.58 B0.24%
2005 โ‚น0.58 B59.56%
2004 โ‚น0.36 B17.77%
2003 โ‚น0.31 B-10.27%
2002 โ‚น0.34 B98.35%
2001 โ‚น0.17 B40.2%
2000 โ‚น0.12 B-16.48%
1999 โ‚น0.14 B46.61%
1998 โ‚น0.10 B-10.46%
1997 โ‚น0.11 B-16.57%
1996 โ‚น0.13 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novavax
NVAX
โ‚น92.02 B 44.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น277.95 B 337.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น241.00 B 278.97%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น3.948 T 6,108.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น3.928 T 6,078.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.315 T 6,685.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.640 T 8,769.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น109.30 B 71.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.95 B-95.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น361.47 B 468.41%๐Ÿ‡บ๐Ÿ‡ธ USA